Lite Strategy

Clinical-stage pharmaceutical company(NASDAQ: LITS)

حول Lite Strategy

التأسيس2018
Lite Strategy, Inc.(NASDAQ: LITS) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
المجتمع
Twitter
Website
العلامات
Publicly listed company
Crypto Stocks

اتجاه تغيير مؤشر الحرارة

لا توجد سجلات

أعضاء الفريق

Frederick W. Driscoll
Frederick W. Driscoll

Chairperson and Non-Executive Director

Justin (Jay) File
Justin (Jay) File

Chief Executive Officer and Chief Financial Officer

تفاصيل جمع التبرعات

Post-IPO(2025-07-21)
المبلغ﷼375.00M
تقييم--